4
Changes in Ownership
ANAPTYSBIO, INC Filed Acc 0001209191-23-049810
Chief Medical Officer sold 2,105 shares at $19.48 ($41,005)
- Chief Medical Officer acquired 6,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Lizzul Paul F. · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-14 | Exercise or conversion : show line 1 in the form | +6,000 | 8,632 | D | ||
| 2023-09-14 | Sale : show line 2 in the form | −2,105 | $19.48 | $41,005 | 6,527 | D |
| Open-market sales · 2,105 sh · avg $19.48 · $41,005 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-09-14 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −6,000 | 6,000 | D |
Loading xslF345X05/doc4.xml…